2023 World Congress of Dermatology

July 3-8, 2023

Singapore


Title: A Phase 2, Randomized, Placebo-controlled, Dose-ranging Study of Oral JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis: FRONTIER 1

Speaker: Bissonnette R (Canada)

Date and Time: July 4, 2023, 14:50 - 15:00


https://www.wcd2023singapore.org/